W World Corp., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat a range of metabolic and nervous system disorders. The company focuses on the disorders of the brain-gut axis, pain/inflammation, and autoimmune, as well as gout disorders. Its lead compounds under clinically development include Levotofisopam, a non-sedating agent for the treatment of Gout; and Dextofisopam, a non-serotonergic agent, which has completed Phase IIa and Phase IIb clinical trials for the treatment of irritable bowel syndrome. The company was founded in 1990 and is headquartered in North Las Vegas, Nevada.
Show more...
CEO
従業員
2
国
US
ISIN
US92942B1035
上場銘柄
0 Comments
意見をシェア
FAQ
W World Corpの株価は今日いくらですか?▼
WWHC の現在価格は $0.02 USD で、過去24時間で +0% 上昇しました。チャートで W World Corp 株価の動きを詳しく確認しましょう。
W World Corpの株式ティッカーは何ですか?▼
取引所によって株式のティッカーは異なる場合があります。たとえば、取引所ではW World Corpの株式はティッカーWWHCで取引されています。